Sumitomo Chemcl (OTCMKTS:SOMMY – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 1.350-1.350 for the period, compared to the consensus EPS estimate of 0.000. The company issued revenue guidance of $15.0 billion-$15.0 billion, compared to the consensus revenue estimate of $17.2 billion.
Sumitomo Chemcl Price Performance
SOMMY stock remained flat at $15.11 during trading hours on Thursday. 1,003 shares of the company’s stock were exchanged, compared to its average volume of 436. Sumitomo Chemcl has a 12-month low of $12.98 and a 12-month high of $20.60. The company has a market capitalization of $5.01 billion, a PE ratio of 12.19 and a beta of 0.34. The company’s fifty day moving average is $16.77 and its 200-day moving average is $16.72. The company has a quick ratio of 0.91, a current ratio of 1.51 and a debt-to-equity ratio of 0.74.
Sumitomo Chemcl (OTCMKTS:SOMMY – Get Free Report) last announced its earnings results on Thursday, May 14th. The company reported ($0.52) EPS for the quarter. The company had revenue of $3.97 billion for the quarter. Sumitomo Chemcl had a return on equity of 5.16% and a net margin of 2.65%.Sumitomo Chemcl has set its FY 2026 guidance at 1.350-1.350 EPS. On average, sell-side analysts forecast that Sumitomo Chemcl will post 1.35 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on Sumitomo Chemcl
About Sumitomo Chemcl
Sumitomo Chemical Co, Ltd. is a diversified chemical company headquartered in Tokyo, Japan. Established in 1913 as part of the historic Sumitomo Group, the company has grown into a global industry leader, operating across multiple chemical and material science industries. It is listed in Japan’s premier equity markets and is available to U.S. investors via its American depositary receipts trading under the ticker SOMMY on the OTCMKTS exchange.
The company’s operations are organized into several core business segments, including petrochemicals, energy and functional materials, ITārelated chemicals, living materials, and health & crop sciences.
See Also
- Five stocks we like better than Sumitomo Chemcl
- Astera Labs’ Post-Earnings Pullback May Be Last Chance to Buy Below $360
- McDonald’s Stock Sell-Off: Justified Warning or Buying Opportunity?
- Why Brown-Forman Rejected a 23% Premium Twice
- Rocket Lab Lands a Wave of Contracts Ahead of Earnings
Receive News & Ratings for Sumitomo Chemcl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Chemcl and related companies with MarketBeat.com's FREE daily email newsletter.
